The Ethical Dilemma Behind the Pharmaceutical Company

1784 Words8 Pages
Introduction One of the biggest controversies in 2009 has been the outbreak of H1N1 influenza, also known as Swine Flu. It began with an outbreak in Mexico, killing one hundred and fifty people in the first week. It is believed that this strain of flu is not like any other. It began with pigs, on a small farm in Mexico. Further, it was transferred to humans and this is when it became lethal to the society (Engdahl, 2009). When the CDC and the Mexican government began to unravel the cause of H1N1, it was discovered that it “shares genetic material from human, avian, and swine influenza viruses” (www.swine-flu-vaccine.info/). Within day, the flu began to spread through out the world, reaching England, Israel, America, and other countries. The WHO, also known as the World Health Organization has declared that … “a public health emergency of international concern; defined by them as an occurrence or immanent threat of illness or health conditions caused by bioterrorism, epidemic, or pandemic disease, or highly fatal infectious agents or toxins that pose serious risk to a significant number of people” (Engdahl, 2009). With this dire news, the pharmaceutical companies like Roche Inc., increased their profit. The demand for flu drugs, most often Tamiflu, has risen and the governments of many nations have isolated millions, if not, billions of dollars to buy Tamiflu. Perhaps, this is not an unusual situation, if it wasn’t for the fact that some of most influential people in the government hold positions in Roche Inc., while others have millions of dollars invested in Tamiflu and Roche Inc. stock (Schwartz, 2005). Much of this has been discussed previously. It is a known fact that Donald Rumsfeld was on the board of Gilead, which is a drug company in California that has created Tamiflu. The drug was than sold to a chemical giant Roche Inc., who pays Gilead royalties

More about The Ethical Dilemma Behind the Pharmaceutical Company

Open Document